Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

AVALONBAY COMMUNITIES INC (AVB) Stock Forecast 2025 - AI Price Prediction & Analysis

AVALONBAY COMMUNITIES INC (AVB) AI Stock Price Forecast & Investment Analysis

AVALONBAY COMMUNITIES INC Stock Price Chart and Technical Analysis

Loading AVALONBAY COMMUNITIES INC interactive price chart and technical analysis...

AVALONBAY COMMUNITIES INC (AVB) - Comprehensive Stock Analysis & Investment Research

Deep dive into AVALONBAY COMMUNITIES INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about AVALONBAY COMMUNITIES INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For AVALONBAY COMMUNITIES INC: AVALONBAY COMMUNITIES INC operates in the Real Estate & Construction sector, positioning it as a large-cap market leader.

AVALONBAY COMMUNITIES INC (Stock Symbol: AVB) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

The organization employs approximately 2 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing AVALONBAY COMMUNITIES INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AVALONBAY COMMUNITIES INC: With $3013M in annual revenue and 2.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $3013 million generating a 2.6% net profit margin .

Market Capitalization: $25207 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 10.4% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for AVALONBAY COMMUNITIES INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For AVALONBAY COMMUNITIES INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for AVALONBAY COMMUNITIES INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: AVALONBAY COMMUNITIES INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For AVALONBAY COMMUNITIES INC: Strong free cash flow generation demonstrates exceptional operational efficiency.

AVALONBAY COMMUNITIES INC strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $1062 million annually, complemented by impressive -7.7% year-over-year cash flow growth.

The company maintains a healthy 28.5% gross margin, indicating strong pricing power and operational efficiency.

AVALONBAY COMMUNITIES INC (AVB) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for AVALONBAY COMMUNITIES INC stock analysis.

Loading AVALONBAY COMMUNITIES INC comprehensive fundamental analysis and insider trading data...

Deep dive into AVALONBAY COMMUNITIES INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if AVALONBAY COMMUNITIES INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For AVALONBAY COMMUNITIES INC: With a P/E ratio of 21.57, the market moderately values the company's earnings.

P/E Ratio 21.57x
P/B Ratio 2.11x
Market Cap $25207M
Dividend Yield 3.93%
EPS $8.16
Book Value/Share $84.33
Revenue/Share $21.28
FCF/Share $8.00
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently AVALONBAY COMMUNITIES INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AVALONBAY COMMUNITIES INC: An ROE of 10.4% shows good shareholder value creation.

ROE 10.4%
ROA 5.8%
ROIC 7.2%
Gross Margin 28.5%
Operating Margin 68.2%
Net Margin 2.6%
EBT Margin 48.1%
Tax Rate 0.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess AVALONBAY COMMUNITIES INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For AVALONBAY COMMUNITIES INC: A current ratio of 1.08 shows adequate liquidity.

Current Ratio 1.08x
Quick Ratio 0.52x
D/E Ratio 0.74x
Financial Leverage 1.81x
Interest Coverage 6.1x
Working Capital $-90M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal AVALONBAY COMMUNITIES INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For AVALONBAY COMMUNITIES INC: Free cash flow of $1062M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $1217M
Free Cash Flow $1062M
Capital Spending $-155M
OCF Growth YoY -7.7%
FCF Growth YoY -8.3%
FCF/Sales 45.0%
CapEx/Sales 6.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively AVALONBAY COMMUNITIES INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For AVALONBAY COMMUNITIES INC: An asset turnover of 0.12x suggests room for improvement in asset utilization.

Asset Turnover 0.12x
Fixed Assets Turnover 15.7x
Payables Period 32 days
Understanding Financial Statement Data

What these metrics mean: Key figures from AVALONBAY COMMUNITIES INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For AVALONBAY COMMUNITIES INC: With annual revenue of $3013M, AVALONBAY COMMUNITIES INC operates at significant scale.

Income Statement ($ Millions)
Total Revenue $3013M
SG&A Expense $3M
Cost of Goods Sold $-809M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 4%
Cash & Short-term Investments 2%
Total Liabilities 45%
Dividend & Shareholder Information
Dividends Per Share $5.00
Payout Ratio 0.7%
Shares Outstanding 142M
Growth Metrics (YoY)
EPS Growth 3.4%

Latest AVALONBAY COMMUNITIES INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting AVALONBAY COMMUNITIES INC (AVB) stock price and investment outlook.

📰 We are currently updating our news feed for AVALONBAY COMMUNITIES INC. Check back soon for the latest market analysis and company updates.

AVALONBAY COMMUNITIES INC Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of AVALONBAY COMMUNITIES INC against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1155M 14.7x 1.0x
ABR Unlock Forecast - 30 Days FREE Trial $1754M 9.0x 0.6x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3474M 16.4x 1.2x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3358M 16.2x 1.1x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4343M 20.4x 1.5x
ACR Unlock Forecast - 30 Days FREE Trial $157M 6.3x 0.4x
ACRE Unlock Forecast - 30 Days FREE Trial $281M 8.5x 0.5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $186M 8.2x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $163M 7.2x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8435M 43.6x 1.4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2035M 10.7x 0.4x
AGNC Unlock Forecast - 30 Days FREE Trial $11392M 13.6x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26517M 68.0x 2.3x
AGNCM Unlock Forecast - 30 Days FREE Trial $26217M 67.7x 2.3x
AGNCN Unlock Forecast - 30 Days FREE Trial $27214M 70.1x 2.4x
AGNCO Unlock Forecast - 30 Days FREE Trial $27000M 69.4x 2.4x
AGNCP Unlock Forecast - 30 Days FREE Trial $26624M 68.3x 2.3x
AHR Unlock Forecast - 30 Days FREE Trial $8163M 299.5x 3.1x
AHT Unlock Forecast - 30 Days FREE Trial $22M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $118M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $85M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $100M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $85M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $85M x x
AIV Unlock Forecast - 30 Days FREE Trial $786M 3.3x 12.7x
AKR Unlock Forecast - 30 Days FREE Trial $2587M 227.8x 1.2x
ALEX Unlock Forecast - 30 Days FREE Trial $1113M 15.2x 1.1x
ALX Unlock Forecast - 30 Days FREE Trial $1098M 29.9x 8.6x
AMH Unlock Forecast - 30 Days FREE Trial $11441M 22.3x 1.6x
AMH-PG Unlock Forecast - 30 Days FREE Trial $8535M x 1.2x
AMH-PH Unlock Forecast - 30 Days FREE Trial $8925M x 1.3x
AMT Unlock Forecast - 30 Days FREE Trial $83759M 28.5x 21.2x
APLE Unlock Forecast - 30 Days FREE Trial $2740M 15.6x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $7744M 55.8x 0.5x
ARI Unlock Forecast - 30 Days FREE Trial $1385M 10.0x 0.7x
ARR Unlock Forecast - 30 Days FREE Trial $1952M 30.2x 0.9x
ARR-PC Unlock Forecast - 30 Days FREE Trial $2372M x 1.1x
AVB Unlock Forecast - 30 Days FREE Trial $25207M 21.6x 2.1x
BDN Unlock Forecast - 30 Days FREE Trial $545M -5.2x 0.7x
BFS Unlock Forecast - 30 Days FREE Trial $731M 18.7x 2.3x
BFS-PD Unlock Forecast - 30 Days FREE Trial $511M 12.7x 1.6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $506M 13.1x 1.6x
BHM Unlock Forecast - 30 Days FREE Trial $37M 15.0x 0.3x
BHR Unlock Forecast - 30 Days FREE Trial $181M -3.1x 0.9x
BHR-PB Unlock Forecast - 30 Days FREE Trial $1030M x 4.9x
BHR-PD Unlock Forecast - 30 Days FREE Trial $1310M x 6.2x
BMNM Unlock Forecast - 30 Days FREE Trial $20M x 0.9x
BNL Unlock Forecast - 30 Days FREE Trial $3317M 37.0x 1.2x
BRSP Unlock Forecast - 30 Days FREE Trial $726M -6.6x 0.7x
BRT Unlock Forecast - 30 Days FREE Trial $262M -37.6x 1.4x
BRX Unlock Forecast - 30 Days FREE Trial $7711M 23.2x 2.6x
BXMT Unlock Forecast - 30 Days FREE Trial $3358M 31.3x 0.9x
BXP Unlock Forecast - 30 Days FREE Trial $10974M 2366.0x 2.2x
CBL Unlock Forecast - 30 Days FREE Trial $1095M 8.8x 3.1x
CCI Unlock Forecast - 30 Days FREE Trial $38837M 36.6x 5.5x
CDP Unlock Forecast - 30 Days FREE Trial $3338M 21.3x 2.2x
CDR-PB Unlock Forecast - 30 Days FREE Trial $246M 46.0x 42.0x
CDR-PC Unlock Forecast - 30 Days FREE Trial $227M 41.3x 38.8x
CHCT Unlock Forecast - 30 Days FREE Trial $435M -220.9x 1.0x
CHMI Unlock Forecast - 30 Days FREE Trial $91M -9.3x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $765M x 3.3x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $867M x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CIM Unlock Forecast - 30 Days FREE Trial $1051M 18.9x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2031M 10.7x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2040M 10.8x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1803M 9.3x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1977M 10.1x 0.8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1808M 9.5x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1984M 10.1x 0.8x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1005M x 1.7x
CLDT Unlock Forecast - 30 Days FREE Trial $319M 36.5x 0.4x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $984M 108.6x 1.3x
CLPR Unlock Forecast - 30 Days FREE Trial $57M -10.4x -20.5x
CMCT Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1113M 152.1x 0.6x
COLD Unlock Forecast - 30 Days FREE Trial $3168M -26.5x 1.0x
CPT Unlock Forecast - 30 Days FREE Trial $11053M 41.1x 2.4x
CSR Unlock Forecast - 30 Days FREE Trial $1080M 35.5x 1.4x
CTO Unlock Forecast - 30 Days FREE Trial $586M 41.8x 1.1x
CTO-PA Unlock Forecast - 30 Days FREE Trial $694M x 1.3x
CTRE Unlock Forecast - 30 Days FREE Trial $8398M 32.1x 2.1x
CUBE Unlock Forecast - 30 Days FREE Trial $8353M 23.5x 3.0x
CUZ Unlock Forecast - 30 Days FREE Trial $4243M 73.7x 0.9x
CXW Unlock Forecast - 30 Days FREE Trial $1961M 18.0x 1.3x
DEA Unlock Forecast - 30 Days FREE Trial $1002M 72.3x 0.8x
DEI Unlock Forecast - 30 Days FREE Trial $1999M 90.0x 1.0x
DHC Unlock Forecast - 30 Days FREE Trial $1157M -1.7x 0.7x
DHCNI Unlock Forecast - 30 Days FREE Trial $4032M -10.4x 2.4x
DLR Unlock Forecast - 30 Days FREE Trial $56509M 40.4x 2.5x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $7532M 5.6x 0.3x
DLR-PK Unlock Forecast - 30 Days FREE Trial $8247M 6.0x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $7248M 5.5x 0.3x
DOC Unlock Forecast - 30 Days FREE Trial $11828M 78.3x 1.6x
DRH Unlock Forecast - 30 Days FREE Trial $1762M 27.5x 1.1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5179M 76.7x 3.3x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $2023M 11.0x 3.5x
DX-PC Unlock Forecast - 30 Days FREE Trial $3785M 48.9x 6.5x
EARN Unlock Forecast - 30 Days FREE Trial $201M -11.6x 0.9x
EGP Unlock Forecast - 30 Days FREE Trial $9598M 38.7x 2.7x
ELME Unlock Forecast - 30 Days FREE Trial $1517M -114.5x 1.7x
ELS Unlock Forecast - 30 Days FREE Trial $11957M 20.1x 6.8x
EPR Unlock Forecast - 30 Days FREE Trial $3971M 19.9x 1.9x
EPR-PC Unlock Forecast - 30 Days FREE Trial $1816M 10.3x 0.9x
EPR-PE Unlock Forecast - 30 Days FREE Trial $2342M 13.1x 1.1x
EPR-PG Unlock Forecast - 30 Days FREE Trial $1582M 8.8x 0.8x
EPRT Unlock Forecast - 30 Days FREE Trial $6073M 25.3x 1.6x
EQIX Unlock Forecast - 30 Days FREE Trial $72814M 68.0x 5.1x
EQR Unlock Forecast - 30 Days FREE Trial $23236M 20.1x 2.1x
ESBA Unlock Forecast - 30 Days FREE Trial $1871M 31.4x x
ESRT Unlock Forecast - 30 Days FREE Trial $1855M 53.2x 1.8x
ESS Unlock Forecast - 30 Days FREE Trial $16447M 19.4x 2.9x
EXR Unlock Forecast - 30 Days FREE Trial $27499M 29.0x 2.0x
FBRT Unlock Forecast - 30 Days FREE Trial $877M 9.2x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1751M 16.8x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2440M 22.4x 1.6x
FISK Unlock Forecast - 30 Days FREE Trial $1836M x x
FPI Unlock Forecast - 30 Days FREE Trial $431M 6.3x 430760.1x
FR Unlock Forecast - 30 Days FREE Trial $7661M 32.3x 2.9x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $8385M 24.2x 2.6x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1747M 5.3x 0.5x
FSP Unlock Forecast - 30 Days FREE Trial $106M -1.9x 0.2x
FVR Unlock Forecast - 30 Days FREE Trial $330M 1175.4x 0.9x
GEDC Unlock Forecast - 30 Days FREE Trial $8M x x
GIPR Unlock Forecast - 30 Days FREE Trial $5M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $11855M 15.3x 2.6x
GMRE Unlock Forecast - 30 Days FREE Trial $441M 176.4x 0.9x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $328M 162.4x 0.7x
GNL Unlock Forecast - 30 Days FREE Trial $1791M -4.5x 1.1x
GNL-PA Unlock Forecast - 30 Days FREE Trial $4956M x 2.9x
GNL-PB Unlock Forecast - 30 Days FREE Trial $4734M x 2.8x
GNL-PD Unlock Forecast - 30 Days FREE Trial $5112M x 3.0x
GNL-PE Unlock Forecast - 30 Days FREE Trial $4984M x 2.9x
GPMT Unlock Forecast - 30 Days FREE Trial $133M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $944M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2561M x 2.9x
HHH Unlock Forecast - 30 Days FREE Trial $5130M 43.5x 1.4x
HIW Unlock Forecast - 30 Days FREE Trial $2909M 22.4x 1.2x
HLTC Unlock Forecast - 30 Days FREE Trial $213M x 0.3x
HST Unlock Forecast - 30 Days FREE Trial $11870M 16.1x 1.8x
ICRP Unlock Forecast - 30 Days FREE Trial $85M 7.5x 0.4x
ICR-PA Unlock Forecast - 30 Days FREE Trial $205M 17.4x 0.9x
IHT Unlock Forecast - 30 Days FREE Trial $11M -57.7x 2.8x
ILPT Unlock Forecast - 30 Days FREE Trial $384M -2.3x 0.8x
IMPM Unlock Forecast - 30 Days FREE Trial $4M x x
INN Unlock Forecast - 30 Days FREE Trial $533M 336.2x 0.6x
INN-PE Unlock Forecast - 30 Days FREE Trial $2101M 241.6x 2.4x
INN-PF Unlock Forecast - 30 Days FREE Trial $2168M 369.2x 2.5x
INRE Unlock Forecast - 30 Days FREE Trial $379M x 1.1x
IOR Unlock Forecast - 30 Days FREE Trial $72M 16.8x 0.6x
IRM Unlock Forecast - 30 Days FREE Trial $24914M 156.4x -41.7x
IRT Unlock Forecast - 30 Days FREE Trial $4005M 179.7x 1.2x
IVR Unlock Forecast - 30 Days FREE Trial $591M 11.1x 0.8x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1717M 40.1x 2.2x
IVT Unlock Forecast - 30 Days FREE Trial $2175M 18.3x 1.2x
JBGS Unlock Forecast - 30 Days FREE Trial $1078M -11.3x 0.6x
KBSR Unlock Forecast - 30 Days FREE Trial $180M x 0.9x
KIM Unlock Forecast - 30 Days FREE Trial $13632M 22.7x 1.3x
KIM-PL Unlock Forecast - 30 Days FREE Trial $13764M 23.8x 1.3x
KIM-PM Unlock Forecast - 30 Days FREE Trial $13950M 24.5x 1.3x
KIM-PN Unlock Forecast - 30 Days FREE Trial $39903M 65.8x 3.8x
KRC Unlock Forecast - 30 Days FREE Trial $4820M 14.9x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $557M 952.5x 0.5x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1179M x 1.0x
KRG Unlock Forecast - 30 Days FREE Trial $4907M 46.7x 1.6x
LADR Unlock Forecast - 30 Days FREE Trial $1383M 17.5x 0.9x
LAMR Unlock Forecast - 30 Days FREE Trial $13514M 31.2x 13.1x
LAND Unlock Forecast - 30 Days FREE Trial $334M 33.9x 0.5x
LANDM Unlock Forecast - 30 Days FREE Trial $905M -119.7x 1.4x
LANDO Unlock Forecast - 30 Days FREE Trial $690M -104.0x 1.0x
LANDP Unlock Forecast - 30 Days FREE Trial $689M -103.5x 1.0x
LFT Unlock Forecast - 30 Days FREE Trial $84M 6.5x 0.4x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1092M 74.5x 4.8x
LINE Unlock Forecast - 30 Days FREE Trial $8065M x 1.0x
LOAN Unlock Forecast - 30 Days FREE Trial $54M 10.9x 1.3x
LTC Unlock Forecast - 30 Days FREE Trial $1677M 49.5x 1.8x
LXP Unlock Forecast - 30 Days FREE Trial $14401M 122.6x 7.0x
LXP-PC Unlock Forecast - 30 Days FREE Trial $13827M 162.3x 6.7x
MAA Unlock Forecast - 30 Days FREE Trial $15416M 27.7x 2.7x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6238M 11.4x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4449M -64.7x 1.8x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8.9x 1.5x
MDV Unlock Forecast - 30 Days FREE Trial $171M -24.6x 1.0x
MDV-PA Unlock Forecast - 30 Days FREE Trial $288M x 1.8x
MFA Unlock Forecast - 30 Days FREE Trial $981M 7.6x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2552M 20.2x 1.4x
MFAO Unlock Forecast - 30 Days FREE Trial $2562M 20.4x 1.4x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2130M 16.6x 1.2x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2421M 19.1x 1.3x
MITN Unlock Forecast - 30 Days FREE Trial $796M 16.3x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $798M 16.3x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $265M 5.3x 0.5x
MITT-PA Unlock Forecast - 30 Days FREE Trial $704M 14.4x 1.3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $698M 13.6x 1.3x
MITT-PC Unlock Forecast - 30 Days FREE Trial $792M 16.1x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $7M x 0.1x
MPW Unlock Forecast - 30 Days FREE Trial $3372M -1.3x 0.7x
NHI Unlock Forecast - 30 Days FREE Trial $3611M 24.5x 2.4x
NHPAP Unlock Forecast - 30 Days FREE Trial $528M x 0.8x
NHPBP Unlock Forecast - 30 Days FREE Trial $513M x 0.8x
NLCP Unlock Forecast - 30 Days FREE Trial $257M 9.8x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $371M x 0.9x
NLY Unlock Forecast - 30 Days FREE Trial $15576M 10.4x 1.0x
NLY-PF Unlock Forecast - 30 Days FREE Trial $17449M x 1.2x
NLY-PG Unlock Forecast - 30 Days FREE Trial $17197M x 1.2x
NLY-PI Unlock Forecast - 30 Days FREE Trial $17449M x 1.2x
NNN Unlock Forecast - 30 Days FREE Trial $7635M 19.5x 1.7x
NREF Unlock Forecast - 30 Days FREE Trial $261M 2.3x 2.0x
NREF-PA Unlock Forecast - 30 Days FREE Trial $410M 4.8x 3.1x
NSA Unlock Forecast - 30 Days FREE Trial $2279M 33.7x 2.3x
NSA-PA Unlock Forecast - 30 Days FREE Trial $1640M x 1.7x
NSA-PB Unlock Forecast - 30 Days FREE Trial $1603M x 1.7x
NTST Unlock Forecast - 30 Days FREE Trial $1467M 7928.3x 1.1x
NXDT Unlock Forecast - 30 Days FREE Trial $142M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $688M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $770M 16.6x 2.4x
NYC Unlock Forecast - 30 Days FREE Trial $21M -0.1x 0.3x
O Unlock Forecast - 30 Days FREE Trial $53795M 55.9x 1.4x
OGCP Unlock Forecast - 30 Days FREE Trial $1841M x x
OLP Unlock Forecast - 30 Days FREE Trial $427M 12.7x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $127M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $1091M 17.8x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3897M 31.4x 7.2x
PCH Unlock Forecast - 30 Days FREE Trial $3004M 46.8x 1.6x
PCOK Unlock Forecast - 30 Days FREE Trial $148M x 0.2x
PEB Unlock Forecast - 30 Days FREE Trial $1228M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2108M x 0.8x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2120M x 0.8x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2152M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $1948M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $4380M 53.5x 1.9x
PGRE Unlock Forecast - 30 Days FREE Trial $1460M -5.8x 0.5x
PINE Unlock Forecast - 30 Days FREE Trial $247M 169.3x 1.1x
PKST Unlock Forecast - 30 Days FREE Trial $508M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $118850M 37.1x 2.3x
PLDGP Unlock Forecast - 30 Days FREE Trial $52005M 15.0x 1.0x
PMT Unlock Forecast - 30 Days FREE Trial $1105M 9.1x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2106M 19.7x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2056M 19.8x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1659M 15.6x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2244M 21.2x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2207M 21.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2230M 21.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $47860M 25.3x 5.1x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3814M 2.2x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3678M 2.1x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4074M 2.4x 0.4x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3471M 2.1x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3348M 2.0x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3393M 2.0x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3291M 1.9x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $2954M 1.7x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2771M 1.6x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2790M 1.6x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2852M 1.7x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2818M 1.6x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2852M 1.6x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $2913M 1.7x 0.3x
PSTL Unlock Forecast - 30 Days FREE Trial $364M 147.2x 1.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
PW-PA Unlock Forecast - 30 Days FREE Trial $14M x 2.2x
RC Unlock Forecast - 30 Days FREE Trial $424M -13.0x 0.2x
RCB Unlock Forecast - 30 Days FREE Trial $3952M -44.3x 2.2x
RCC Unlock Forecast - 30 Days FREE Trial $4014M -45.2x 2.3x
RCD Unlock Forecast - 30 Days FREE Trial $3819M x 2.2x
RC-PC Unlock Forecast - 30 Days FREE Trial $2266M x 1.3x
RC-PE Unlock Forecast - 30 Days FREE Trial $2279M x 1.3x
REFI Unlock Forecast - 30 Days FREE Trial $269M 7.5x 0.9x
REG Unlock Forecast - 30 Days FREE Trial $12519M 38.5x 1.8x
REGCO Unlock Forecast - 30 Days FREE Trial $4138M x 0.6x
REGCP Unlock Forecast - 30 Days FREE Trial $4341M x 0.6x
REXR Unlock Forecast - 30 Days FREE Trial $9482M 27.9x 1.1x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5301M 17.1x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5115M 15.3x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $5780M 23.9x 7.6x
RITM Unlock Forecast - 30 Days FREE Trial $6285M 7.0x 0.7x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14005M 16.9x 1.7x
RITM-PB Unlock Forecast - 30 Days FREE Trial $13910M 16.8x 1.6x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13578M 16.4x 1.6x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13528M 16.3x 1.6x
RLJ Unlock Forecast - 30 Days FREE Trial $1098M 32.8x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3791M 65.8x 1.7x
RPT Unlock Forecast - 30 Days FREE Trial $122M -0.8x 0.4x
RPT-PC Unlock Forecast - 30 Days FREE Trial $1136M x 3.9x
RWT Unlock Forecast - 30 Days FREE Trial $721M 31.3x 0.7x
RWTN Unlock Forecast - 30 Days FREE Trial $3169M x 3.2x
RWTO Unlock Forecast - 30 Days FREE Trial $3124M x 3.1x
RWTP Unlock Forecast - 30 Days FREE Trial $3078M x 3.1x
RWT-PA Unlock Forecast - 30 Days FREE Trial $3080M x 3.1x
SACH Unlock Forecast - 30 Days FREE Trial $49M 21.3x 0.3x
SACH-PA Unlock Forecast - 30 Days FREE Trial $889M x 5.1x
SAFE Unlock Forecast - 30 Days FREE Trial $986M 8.8x 0.4x
SBAC Unlock Forecast - 30 Days FREE Trial $20242M 23.6x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4750M 27.1x 1.7x
SCCC Unlock Forecast - 30 Days FREE Trial $1192M 361.5x 6.8x
SCCD Unlock Forecast - 30 Days FREE Trial $1140M 304.5x 6.5x
SCCE Unlock Forecast - 30 Days FREE Trial $1104M 304.8x 6.3x
SCCF Unlock Forecast - 30 Days FREE Trial $1102M 279.9x 6.3x
SCCG Unlock Forecast - 30 Days FREE Trial $1104M 325.2x 6.3x
SELF Unlock Forecast - 30 Days FREE Trial $58M 22.8x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $132M 10.5x 0.5x
SILA Unlock Forecast - 30 Days FREE Trial $1282M 32.7x 1.0x
SITC Unlock Forecast - 30 Days FREE Trial $380M 1.3x 1.2x
SKT Unlock Forecast - 30 Days FREE Trial $3714M 45.7x 5.3x
SLG Unlock Forecast - 30 Days FREE Trial $3103M 182.4x 0.8x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1523M x 0.4x
SMA Unlock Forecast - 30 Days FREE Trial $1014M x 0.8x
SOHO Unlock Forecast - 30 Days FREE Trial $44M -1.4x 1.2x
SOHOB Unlock Forecast - 30 Days FREE Trial $351M -21.4x 9.5x
SOHON Unlock Forecast - 30 Days FREE Trial $314M -21.8x 8.6x
SOHOO Unlock Forecast - 30 Days FREE Trial $358M -25.6x 9.7x
SPG Unlock Forecast - 30 Days FREE Trial $59593M 26.5x 25.4x
SPG-PJ Unlock Forecast - 30 Days FREE Trial $17754M x 7.6x
SQFT Unlock Forecast - 30 Days FREE Trial $38M 1.2x 1.1x
SQFTP Unlock Forecast - 30 Days FREE Trial $139M 24.7x 3.9x
STAG Unlock Forecast - 30 Days FREE Trial $7244M 30.1x 2.1x
STLY Unlock Forecast - 30 Days FREE Trial $26M 37.8x 0.6x
STRW Unlock Forecast - 30 Days FREE Trial $172M 24.4x 12.0x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $6755M 18.4x 1.0x
SUI Unlock Forecast - 30 Days FREE Trial $15850M 15.1x 2.3x
SUNS Unlock Forecast - 30 Days FREE Trial $135M 13.4x 0.7x
SVC Unlock Forecast - 30 Days FREE Trial $307M -2.2x 0.5x
TCI Unlock Forecast - 30 Days FREE Trial $389M 58.9x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $203M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $580M x 3.6x
TRTX Unlock Forecast - 30 Days FREE Trial $708M 10.6x 0.7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1421M 20.7x 1.3x
TWO Unlock Forecast - 30 Days FREE Trial $1073M 15.2x 0.4x
TWOD Unlock Forecast - 30 Days FREE Trial $2647M x 1.1x
TWO-PA Unlock Forecast - 30 Days FREE Trial $2445M x 1.0x
TWO-PB Unlock Forecast - 30 Days FREE Trial $2360M x 1.0x
TWO-PC Unlock Forecast - 30 Days FREE Trial $2489M x 1.0x
UDR Unlock Forecast - 30 Days FREE Trial $11643M 77.8x 3.6x
UHT Unlock Forecast - 30 Days FREE Trial $550M 30.7x 3.5x
UMH Unlock Forecast - 30 Days FREE Trial $1303M 48.5x 1.4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1890M 63.1x 2.0x
VICI Unlock Forecast - 30 Days FREE Trial $29638M 10.6x 1.1x
VNO Unlock Forecast - 30 Days FREE Trial $6687M 7.4x 1.1x
VNO-PL Unlock Forecast - 30 Days FREE Trial $3396M 4.0x 0.6x
VNO-PM Unlock Forecast - 30 Days FREE Trial $3399M 4.0x 0.6x
VNO-PN Unlock Forecast - 30 Days FREE Trial $3332M 4.0x 0.6x
VNO-PO Unlock Forecast - 30 Days FREE Trial $2862M 3.3x 0.5x
VNORP Unlock Forecast - 30 Days FREE Trial $12772M 17.9x 2.1x
VRE Unlock Forecast - 30 Days FREE Trial $1361M 21.6x 1.2x
VTR Unlock Forecast - 30 Days FREE Trial $37842M 159.0x 3.1x
WELL Unlock Forecast - 30 Days FREE Trial $139770M 145.5x 3.6x
WHLR Unlock Forecast - 30 Days FREE Trial $3M 1.7x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $32M 17.5x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $85M 56.0x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $4M 2.0x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14531M 39.8x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $675M 15.2x 1.5x
WY Unlock Forecast - 30 Days FREE Trial $15635M 47.2x 1.7x

Frequently Asked Questions - AVALONBAY COMMUNITIES INC Stock Forecast

How accurate are AVALONBAY COMMUNITIES INC stock predictions?

Our AI model shows a 62% Spearman correlation coefficient for AVB predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence AVALONBAY COMMUNITIES INC stock price forecasts?

Our analysis considers AVALONBAY COMMUNITIES INC's financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is AVALONBAY COMMUNITIES INC a good investment in 2025?

Based on our AI analysis, AVALONBAY COMMUNITIES INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are AVALONBAY COMMUNITIES INC forecasts updated?

AVALONBAY COMMUNITIES INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced AVALONBAY COMMUNITIES INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for AVALONBAY COMMUNITIES INC stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...